首页> 美国卫生研究院文献>RNA Biology >Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy
【2h】

Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy

机译:智能功能核酸嵌合体:实现组织特异性RNA靶向治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense, antimiRs etc. is to deliver them specifically to the target tissues. Toward this goal, nucleic acid aptamers are re-emerging as a prominent class of biomolecules capable of delivering target specific therapy and therapeutic monitoring by various molecular imaging modalities. This class of short oligonucleotide ligands with high affinity and specificity are selected from a large nucleic acid pool against a molecular target of choice. Poor cellular uptake of therapeutic oligonucleotides impedes gene-targeting efficacy in vitro and in vivo. In contrast, aptamer-oligonucleotide chimeras have shown the capacity to deliver siRNA, antimiRs, small molecule drugs etc. toward various targets and showed very promising results in various studies on different diseases models. However, to further improve the bio-stability of such chimeric conjugates, it is important to introduce chemically-modified nucleic acid analogs. In this review, we highlight the applications of nucleic acid aptamers for target specific delivery of therapeutic oligonucleotides.
机译:有效利用治疗性寡核苷酸(如siRNA,反义,antimiRs等)的主要障碍是将其特异地递送至靶组织。为了实现这一目标,核酸适体作为一种重要的生物分子正在重新出现,它们能够通过各种分子成像方式进行靶标特异性治疗和治疗监测。具有高亲和力和特异性的这类短寡核苷酸配体选自针对所选分子靶标的大核酸库。治疗性寡核苷酸的细胞摄取差会在体外和体内阻碍基因靶向功效。相反,适体-寡核苷酸嵌合体已经显示出向各种靶标递送siRNA,antimiRs,小分子药物等的能力,并且在针对不同疾病模型的各种研究中显示出非常有希望的结果。然而,为了进一步改善这种嵌合缀合物的生物稳定性,重要的是引入化学修饰的核酸类似物。在这篇综述中,我们重点介绍了核酸适体在治疗性寡核苷酸靶向特异性递送中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号